跳至主導覽 跳至搜尋 跳過主要內容

Assessment of patient-reported clinical outcome in pancreatic and other hepatobiliary cancers: The FACT Hepatobiliary Symptom Index

  • Susan Yount*
  • , David Cella
  • , Kimberly Webster
  • , Nancy Heffernan
  • , Chih Hung Chang
  • , Linda Odom
  • , Renilt Van Gool
  • *此作品的通信作者
  • Research and Education
  • Northwestern University
  • Memorial Sloan-Kettering Cancer Center
  • Johnson & Johnson

研究成果: 期刊稿件 › 文章 › 同儕審查

78 引文 斯高帕斯(Scopus)

摘要

This study's aim was to develop and validate a symptom index derived from the Functional Assessment of Cancer Therapy-Hepatobiliary, a questionnaire measuring general and hepatobiliary disease specific aspects of quality of life. The item pool was narrowed to 26 questions that assess symptoms and function. Each of 95 hepatobiliary cancer experts narrowed the list to 5 of the most important to attend to when treating advanced hepatobiliary disease. Eight symptoms were endorsed by more than 20% of the experts (3 pain, 2 fatigue, nausea, weight loss, jaundice) and were named the FACT-Hepatobiliary Symptom Index-8 (FHSI-8). Among 51 hepatobiliary cancer patients, the FHSI-8 showed good internal consistency (0.79), test-retest reliability (r = 0.86), strong association with mood (r = -0.56), and patient differentiation by ECOG Performance Status Rating ( P < 0.0001) and treatment status ( P = 0.057). Symptom scaling in diseases such as hepatobiliary cancer is feasible and may provide an efficient, clinically-relevant endpoint for following groups over time.

原文英語
頁(從 - 到)32-44
頁數13
期刊Journal of Pain and Symptom Management
卷24
發行號1
DOIs
出版品狀態已出版 - 2002
對外發佈是

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Assessment of patient-reported clinical outcome in pancreatic and other hepatobiliary cancers: The FACT Hepatobiliary Symptom Index」主題。共同形成了獨特的指紋。

引用此